PARP1 and neoplasm: As a key tool for real-time monitoring of the status of tumor DNA damage repair, PARP-1 PET imaging agents have made remarkable progress in recent years in aspects such as the development of novel imaging agents (e.g., [18F]-PARPZ), personalized treatment strategies (screening patients sensitive to PARP inhibitors), and the combination of multimodal imaging techniques.